Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.

Saved in:
Bibliographic Details
Title: Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
Authors: Zhang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Lu Y; Department of Pharmacy, The Third People's Hospital of Chengdu, Chengdu, China., Kwong JS; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan., Li X; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China., Zheng W; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden., He R; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden.
Source: Frontiers in pharmacology [Front Pharmacol] 2020 Aug 27; Vol. 11, pp. 1330. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020).
Publication Type: Systematic Review; Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32973535
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Pharmacy, The Third People's Hospital of Chengdu, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Kwong+JS%22">Kwong JS</searchLink>; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Zheng+W%22">Zheng W</searchLink>; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22He+R%22">He R</searchLink>; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2020 Aug 27; Vol. 11, pp. 1330. <i>Date of Electronic Publication: </i>2020 Aug 27 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Systematic Review; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32973535
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2020.01330
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1330
    Titles:
      – TitleFull: Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Lu Y
      – PersonEntity:
          Name:
            NameFull: Kwong JS
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Zheng W
      – PersonEntity:
          Name:
            NameFull: He R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 08
              Text: 2020 Aug 27
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1